カテゴリ： MarketLine, ドイツ, 企業調査

H. Butting GmbH & Co KG：企業の戦略・SWOT・財務情報

◆英語タイトル：H. Butting GmbH & Co KG - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6650
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：25
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：金属・鉱業
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

H. Butting GmbH & Co KG – Strategy, SWOT and Corporate Finance Report
Summary

H. Butting GmbH & Co KG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

H. Butting GmbH & Co KG (Butting) is a manufacturer of stainless steel and clad materials. The company’s major products include corrosion resistant pipes; clad pipes; special pipes and components; spools and welded components; vessels, tanks and columns; and assemblies. It serves various industries including engineering and construction, architecture and design, drilling and well building, chemical, power engineering, food, aircraft and aerospace, seawater desalination, oil and gas, paper and pulp, pharmaceutical and biochemistry, pneumatic conveyor systems, pumps technology, shipbuilding, environmental, water and wastewater technology, among others. The company distributes products directly and also through a network of distributors across North America, South America, Europe, the Middle East and Asia. Butting is headquartered in Knesebeck, Germany.

Scope

- Detailed information on H. Butting GmbH & Co KG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting H. Butting GmbH & Co KG in the form of a SWOT analysis
- An in-depth view of the business model of H. Butting GmbH & Co KG including a breakdown and examination of key business segments
- Intelligence on H. Butting GmbH & Co KG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about H. Butting GmbH & Co KG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of H. Butting GmbH & Co KG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess H. Butting GmbH & Co KG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on H. Butting GmbH & Co KG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
H. Butting GmbH & Co KG: Company Overview 6
H. Butting GmbH & Co KG: Overview and Key Facts 6
H. Butting GmbH & Co KG: Overview 6
H. Butting GmbH & Co KG: Key Facts 6
H. Butting GmbH & Co KG: Key Employees 7
H. Butting GmbH & Co KG: Major Products and Services 9
H. Butting GmbH & Co KG: Company History 10
H. Butting GmbH & Co KG: Management Statement 12
H. Butting GmbH & Co KG: Locations and Subsidiaries 13
H. Butting GmbH & Co KG: Key Competitors 14
H. Butting GmbH & Co KG: Company Analysis 15
H. Butting GmbH & Co KG: Business Description 15
H. Butting GmbH & Co KG: SWOT Analysis 16
H. Butting GmbH & Co KG: SWOT Overview 16
H. Butting GmbH & Co KG: Strengths 16
H. Butting GmbH & Co KG: Weaknesses 17
H. Butting GmbH & Co KG: Opportunities 17
H. Butting GmbH & Co KG: Threats 18
H. Butting GmbH & Co KG: Recent Developments 19
H. Butting GmbH & Co KG: News and Events Summary 19
H. Butting GmbH & Co KG: Business Expansion 20
H. Butting GmbH & Co KG: Contracts 20
H. Butting GmbH & Co KG: Corporate Governance 21
H. Butting GmbH & Co KG: Strategy and Operations 21
Appendix 23
Contact Us 23
Methodology 23
About MarketLine 24

List of Tables
Table 1: H. Butting GmbH & Co KG: Key Facts
Table 2: H. Butting GmbH & Co KG: Key Employees
Table 3: H. Butting GmbH & Co KG: Company History
Table 4: H. Butting GmbH & Co KG: Locations and Subsidiaries
Table 5: H. Butting GmbH & Co KG: Key Competitors
Table 6: H. Butting GmbH & Co KG: News and Events Summary
Table 7: H. Butting GmbH & Co KG: Business Expansion
Table 8: H. Butting GmbH & Co KG: Contracts
Table 9: H. Butting GmbH & Co KG: Corporate Governance
Table 10: H. Butting GmbH & Co KG: Strategy and Operations



★海外企業調査レポート[H. Butting GmbH & Co KG：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • DSG Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary DSG Inc (DSG) is a provider of eClinical software solutions. The company offers software products such as eCaseLink EDC, eClinDirect CTMS, eCaseLink.Me ePRO, DSG Drug Safety, eCaseLink IRT, DSG Designer, CaseXport, CaseView Imaging, and others. Its services include data management, technolog …
  • Arno Therapeutics Inc (ARNI)-製薬・医療分野：企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Alfa Group Consortium：企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Teleflex Inc (TFX)：企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SIFI SpA-製薬・医療分野：企業M&A・提携分析
    Summary SIFI SpA (SIFI) is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of the most common ocular pathologies. SIFI develops its produc …
  • Mithra Pharmaceuticals SA (MITRA)：医療機器：M&Aディール及び事業提携情報
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • Securitas AB：企業の戦略・SWOT・財務分析
    Securitas AB - Strategy, SWOT and Corporate Finance Report Summary Securitas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Aclara Technologies LLC-エネルギー分野：企業M&A・提携分析
    Summary Aclara Technologies LLC (Aclara), as a subsidiary of Sun Capital Partners, Inc. The company designs, develops and commercializes Advanced Metering Infrastructure (AMI) solutions for data value management, customer communication and device networking activities. It provides an array of custom …
  • Adaptimmune Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Adaptimmune Ltd (Adaptimmune), a subsidiary of Adaptimmune Therapeutics Plc is a clinical stage biotechnology company that develops T-cell therapy products for the treatment of cancer. The company’s pipeline peptides include NY-ESO TCR used to treat cancer cells, MAGE A-10 TCR used for the t …
  • EnviTec Biogas AG (ETG)：企業の財務・戦略的SWOT分析
    EnviTec Biogas AG (ETG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CVS Health Corp (CVS)：製薬・医療：M&Aディール及び事業提携情報
    Summary CVS Health Corporation (CVS) is an integrated prescription and related health services provider. The company offers a range of solutions such as prescription medications; health care products; popular beauty, health and personal care brands; retail-based health clinical services; and pharmac …
  • Energy Development Corporation (EDC)：企業の財務・戦略的SWOT分析
    Energy Development Corporation (EDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Stratasys Ltd：企業の戦略・SWOT・財務情報
    Stratasys Ltd - Strategy, SWOT and Corporate Finance Report Summary Stratasys Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • IntriCon Corp (IIN)：医療機器：M&Aディール及び事業提携情報
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support product …
  • Grifols SA (GRF)：製薬・医療：M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Builders FirstSource Inc：企業の戦略・SWOT・財務情報
    Builders FirstSource Inc - Strategy, SWOT and Corporate Finance Report Summary Builders FirstSource Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • AroCell AB (AROC)：製薬・医療：M&Aディール及び事業提携情報
    Summary AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the …
  • Centre for Commercialization of Regenerative Medicine-製薬・医療分野：企業M&A・提携分析
    Summary Centre for Commercialization of Regenerative Medicine (CCRM) is an healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, bio materials and devices manufacturing. The center’s cell reprogramming and engineering offers various capabilities such as esta …
  • Berliner Volksbank eG：企業の戦略・SWOT・財務情報
    Berliner Volksbank eG - Strategy, SWOT and Corporate Finance Report Summary Berliner Volksbank eG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • National Beef Packing Company LLC：企業の戦略・SWOT・財務情報
    National Beef Packing Company LLC - Strategy, SWOT and Corporate Finance Report Summary National Beef Packing Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆